Form 4 Filing for Recursion Pharmaceuticals, Inc. - Officer Stock Transaction

This filing details a stock transaction by Ben R Taylor, the Chief Financial Officer of Recursion Pharmaceuticals, Inc. On April 6, 2026, Mr. Taylor disposed of 48,028 shares of Class A Common Stock at a price of $3.11 per share. This transaction was related to tax withholding obligations in connection with the net settlement of restricted stock units, as indicated by footnote F1. Following this transaction, Mr. Taylor owns 1,132,290 shares of Class A Common Stock directly. The filing was signed by an attorney-in-fact on April 8, 2026.